Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1AstraZeneca Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

AstraZeneca Canada Inc.

arrow
CPHI Shenzhen
Not Confirmed

AstraZeneca Canada Inc.

Country
arrow
CPHI Shenzhen
Not Confirmed

Durvalumab

Brand Name : IMFINZI

Patent Number : 2778714

Filing Date : 2010-11-24

Strength per Unit : 50mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2030-11-24

Date Granted : 2018-02-27

blank